Kuang M - Search Results

1

US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment.

Huang H, Cheng MQ, He DN, Xian MF, Zeng D, Wu SH, Li CQ, Ruan SM, Li MD, Lin MX, Lu MD, Kuang M, Wang W, Chen LD. Huang H, et al. Among authors: kuang m. Eur Radiol. 2023 Dec;33(12):9357-9367. doi: 10.1007/s00330-023-09903-7. Epub 2023 Jul 18. Eur Radiol. 2023. PMID: 37460801

2

[Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma].

Liang L, Huang J, Yin X, Lu M, Rao G, Ren Z, Li D, Kuang M. Liang L, et al. Among authors: kuang m. Zhonghua Wai Ke Za Zhi. 1999 Dec;37(12):743-6. Zhonghua Wai Ke Za Zhi. 1999. PMID: 11829942 Chinese.

3

Tumor vaccine against recurrence of hepatocellular carcinoma.

Peng BG, Liang LJ, He Q, Kuang M, Lia JM, Lu MD, Huang JF. Peng BG, et al. Among authors: kuang m. World J Gastroenterol. 2005 Feb 7;11(5):700-4. doi: 10.3748/wjg.v11.i5.700. World J Gastroenterol. 2005. PMID: 15655825 Free PMC article. Clinical Trial.

4

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

Yin XY, Lü MD, Liang LJ, Lai JM, Li DM, Kuang M. Yin XY, et al. Among authors: kuang m. World J Gastroenterol. 2005 Apr 28;11(16):2526-9. doi: 10.3748/wjg.v11.i16.2526. World J Gastroenterol. 2005. PMID: 15832431 Free PMC article. Clinical Trial.

5

Microwave tumour coagulation plus in situ treatment with cytokine-microparticles: induction of potent anti-residual tumour immunity.

Kuang M, Liu SQ, Saijo K, Uchimura E, Huang L, Leong KW, Lu MD, Huang JF, Ohno T. Kuang M, et al. Int J Hyperthermia. 2005 May;21(3):247-57. doi: 10.1080/02656730500052027. Int J Hyperthermia. 2005. PMID: 16019851 Free article.

6

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ. Xu HX, et al. Among authors: kuang m. Clin Radiol. 2005 Sep;60(9):1018-25. doi: 10.1016/j.crad.2005.04.009. Clin Radiol. 2005. PMID: 16124984

7

Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.

Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Lu MD, et al. Among authors: kuang m. J Gastroenterol. 2005 Nov;40(11):1054-60. doi: 10.1007/s00535-005-1671-3. J Gastroenterol. 2005. PMID: 16322950

8

[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].

Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM, Li SQ. Lü MD, et al. Among authors: kuang m. Zhonghua Yi Xue Za Zhi. 2006 Mar 28;86(12):801-5. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16681964 Clinical Trial. Chinese.

9

Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.

Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J. Peng B, et al. Among authors: kuang m. Hepatogastroenterology. 2006 May-Jun;53(69):409-14. Hepatogastroenterology. 2006. PMID: 16795983 Clinical Trial.

10

Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.

Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M, Liu GJ, Liang JY, Lau WY. Yin XY, et al. Among authors: kuang m. Cancer. 2009 May 1;115(9):1914-23. doi: 10.1002/cncr.24196. Cancer. 2009. PMID: 19241423 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

730 results

Search Page

Filters